Georgia Urology is a clinical research site located in Atlanta, Georgia, United States 30328.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
Georgia Urology has participated in 14 clinical trials with 4 currently active.
Therapeutic areas: Non-muscle Invasive Bladder Cancer, NMIBC, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ.
Sponsors: ImmunityBio, Inc., Ferring Pharmaceuticals, Boston Scientific Corporation.
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Georgia Urology has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Georgia Urology has 14 clinical trials on record, with 4 currently active. Their work covers Non-muscle Invasive Bladder Cancer, NMIBC, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ.
Yes — Georgia Urology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.